Axil Brands, Inc. earnings releases AXIL

Axil Brands, Inc. last reported quarterly results on Oct 6, 2026, for Q1 FY2027 (the quarter ended Aug 31, 2026): revenue of $6.1 million (-11.2% year over year) and diluted EPS of $0.05. It usually reports 36–39 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 7, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 36–39 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Oct 6, 2026
36 days after quarter end
Q1 FY2027
ended Aug 31, 2026
6
-11.2%
0
+25.8%
0.05
+25.0%
Apr 8, 2026
39 days after quarter end
Q3 FY2026
ended Feb 28, 2026
7
+5.4%
0
-64.8%
0.02
-71.4%
Jan 8, 2026
39 days after quarter end
Q2 FY2026
ended Nov 30, 2025
8
+5.2%
1
+11.2%
0.09
+12.5%
Oct 7, 2025
37 days after quarter end
Q1 FY2026
ended Aug 31, 2025
7
0
0.04
Apr 8, 2025
39 days after quarter end
Q3 FY2025
ended Feb 28, 2025
7
+7.0%
1
-26.2%
0.07
+75.0%
Jan 8, 2025
39 days after quarter end
Q2 FY2025
ended Nov 30, 2024
8
-8.2%
1
-37.8%
0.08
+60.0%
Oct 10, 2024
40 days after quarter end
—
ended Aug 31, 2024
—
—
—
Apr 10, 2024
41 days after quarter end
—
ended Feb 29, 2024
—
—
—

Company profile

Industry
Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
Listed as
AXIL (NYSE)
Fiscal year ends
May 31
Incorporated in
DE
Headquarters
Beverly Hills, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1718500
Former names
Reviv3 Procare Co (until Feb 13, 2024)

Other Perfumes, Cosmetics & Other Toilet Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.